These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29370485)

  • 21. Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule.
    Verduijn J; Verhoeven JE; Milaneschi Y; Schoevers RA; van Hemert AM; Beekman ATF; Penninx BWJH
    BMC Med; 2017 Dec; 15(1):215. PubMed ID: 29228943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.
    Ionescu DF; Luckenbaugh DA; Niciu MJ; Richards EM; Slonena EE; Vande Voort JL; Brutsche NE; Zarate CA
    J Clin Psychiatry; 2014 Sep; 75(9):e932-8. PubMed ID: 25295436
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinically useful self-report measure of the DSM-5 mixed features specifier of major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Martinez JH
    J Affect Disord; 2014 Oct; 168():357-62. PubMed ID: 25103631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.
    Balestri M; Calati R; Souery D; Kautzky A; Kasper S; Montgomery S; Zohar J; Mendlewicz J; Serretti A
    J Affect Disord; 2016 Jan; 189():224-32. PubMed ID: 26451508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and external validation of a prediction rule for an unfavorable course of late-life depression: A multicenter cohort study.
    Maarsingh OR; Heymans MW; Verhaak PF; Penninx BWJH; Comijs HC
    J Affect Disord; 2018 Aug; 235():105-113. PubMed ID: 29655070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS).
    Hardeveld F; Spijker J; De Graaf R; Nolen WA; Beekman AT
    Psychol Med; 2013 Jan; 43(1):39-48. PubMed ID: 23111147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Categorical and dimensional stability of comorbid personality disorder symptoms in DSM-IV major depressive disorder: a prospective study.
    Melartin TK; Haukka J; Rytsälä HJ; Jylhä PJ; Isometsä ET
    J Clin Psychiatry; 2010 Mar; 71(3):287-95. PubMed ID: 20079331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting outcome of depression using the depressive symptom profile: the Leiden Routine Outcome Monitoring Study.
    van Noorden MS; van Fenema EM; van der Wee NJ; Zitman FG; Giltay EJ
    Depress Anxiety; 2012 Jun; 29(6):523-30. PubMed ID: 22555849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Course and outcome of depressive disorders in primary care: a prospective 18-month study.
    Vuorilehto MS; Melartin TK; Isometsä ET
    Psychol Med; 2009 Oct; 39(10):1697-707. PubMed ID: 19250580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA).
    Penninx BW; Nolen WA; Lamers F; Zitman FG; Smit JH; Spinhoven P; Cuijpers P; de Jong PJ; van Marwijk HW; van der Meer K; Verhaak P; Laurant MG; de Graaf R; Hoogendijk WJ; van der Wee N; Ormel J; van Dyck R; Beekman AT
    J Affect Disord; 2011 Sep; 133(1-2):76-85. PubMed ID: 21496929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression.
    Phillips JL; Batten LA; Tremblay P; Aldosary F; Blier P
    Int J Neuropsychopharmacol; 2015 Mar; 18(8):. PubMed ID: 25829180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional versus syndromal recovery in patients with major depressive disorder and bipolar disorder.
    van der Voort TY; Seldenrijk A; van Meijel B; Goossens PJ; Beekman AT; Penninx BW; Kupka RW
    J Clin Psychiatry; 2015 Jun; 76(6):e809-14. PubMed ID: 26132690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.
    Bauer M; Dell'osso L; Kasper S; Pitchot W; Dencker Vansvik E; Köhler J; Jørgensen L; Montgomery SA
    J Affect Disord; 2013 Oct; 151(1):209-19. PubMed ID: 23810357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of major and minor depressive episodes and associated risk indicators in a psychiatric epidemiological cohort study of the general population.
    Ten Have M; Penninx BWJH; Tuithof M; van Dorsselaer S; Kleinjan M; Spijker J; de Graaf R
    Acta Psychiatr Scand; 2017 Sep; 136(3):300-312. PubMed ID: 28512767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refining Prediction in Treatment-Resistant Depression: Results of Machine Learning Analyses in the TRD III Sample.
    Kautzky A; Dold M; Bartova L; Spies M; Vanicek T; Souery D; Montgomery S; Mendlewicz J; Zohar J; Fabbri C; Serretti A; Lanzenberger R; Kasper S
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 29228516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sleep duration, but not insomnia, predicts the 2-year course of depressive and anxiety disorders.
    van Mill JG; Vogelzangs N; van Someren EJ; Hoogendijk WJ; Penninx BW
    J Clin Psychiatry; 2014 Feb; 75(2):119-26. PubMed ID: 24345733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease.
    Frasure-Smith N; Lespérance F
    Arch Gen Psychiatry; 2008 Jan; 65(1):62-71. PubMed ID: 18180430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severity, course trajectory, and within-person variability of individual symptoms in patients with major depressive disorder.
    van Eeden WA; van Hemert AM; Carlier IVE; Penninx BW; Giltay EJ
    Acta Psychiatr Scand; 2019 Feb; 139(2):194-205. PubMed ID: 30447008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.